Clinical Trials Directory

Trials / Completed

CompletedNCT00000280

Glutaminergic Agents for Cocaine Abuse - 5

Glutaminergic Agents for Cocaine Abuse

Status
Completed
Phase
Phase 1
Study type
Interventional
Enrollment
0 (planned)
Sponsor
Yale University · Academic / Other
Sex
All
Age
18 Years – 45 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to evaluate glutaminergic agents for cocaine abuse.

Conditions

Interventions

TypeNameDescription
DRUGNimodipine

Timeline

Start date
1994-09-01
Primary completion
1999-08-01
Completion
1999-08-01
First posted
1999-09-21
Last updated
2017-04-25

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT00000280. Inclusion in this directory is not an endorsement.